PRESCIENT THERAPEUTICS LIMITED - News & Media

5.80%

6.5¢

Market Cap $73.60M

Healthcare Biotechnology

Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing... Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cell therapies.More

Compumedics Limited (ASX:CMP): FDA-Cleared AI Sleep & Brain Imaging Platforms. SaaS Recurring Revenues. U.S. Expansion Underway. CMP is Unlocking the Next MedTech Growth Story.

Articles & Videos

Prescient Therapeutics jumps +15% on EU regulator interest in PTX-100

Prescient Therapeutics has jumped +15% after EU drug regulator European Medicines Agency awarded orphan drug designation.

19 Nov 2025 12:31 (AEDT)

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

It’s no secret that the rate of cancer both in Australia, and overseas, appears to be increasing – particularly among...

21 Jul 2025 06:00 (AEST)

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

In this HotCopper Capital Compass interview, Prescient Therapeutics (ASX: PTX) CEO James McDonnell discusses the company’s progress with PTX-100, a first-in-class therapy targeting the RAS pathway in cancer.Listen to the HotCopper podcast for in-depth discussions and insights on a...

26 Jun 2025 09:25 (AEST)

FDA grants Prescient Therapeutics (ASX:PTX) broad orphan drug status for PTX-100 cancer treatment

Oncology company Prescient Therapeutics (ASX:PTX) has been granted broad orphan drug designation (ODD) for its PTX-100 drug by the US Food and Drug Administration (FDA).

09 Mar 2023 12:08 (AEDT)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.5¢		Change -0.004(5.80%)		Mkt cap ! $73.60M

Open	High	Low	Volume
6.8¢	6.8¢	6.5¢	1.791M

Buyers (Bids)

Vol.	Price($)
41889	6.5¢

Sellers (Offers)

Price($)	Vol.
6.7¢	54304

Last trade - 14.47pm 12/02/2026 (20 minute delay)

PTX (ASX) Chart